XML 47 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Accrued expenses and other current liabilities - Narrative (Details)
1 Months Ended 3 Months Ended 6 Months Ended 13 Months Ended
Jun. 30, 2018
Jun. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
employee
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)   $ 0 $ (11,000) $ 1,765,000
Number of retained employees | employee       7
One-time termination benefits        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)     3,000 $ 97,000
Termination and retention benefits        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       1,355,000
Ongoing termination benefits        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)     8,000 1,029,000
Employee retention benefits        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       214,000
Other        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       15,000
Research and development        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)     (11,000) 957,000
Selling, general and administrative        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       808,000
Consumer Operations        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       94,000
Drug Development        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)     (11,000) 957,000
Corporate        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       714,000
Minimum        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       1,765,000
Maximum        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       3,343,000
Maximum | Consumer Operations        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       114,000
Maximum | Drug Development        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       1,024,000
Maximum | Corporate        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credit)       2,205,000
Corporate restructuring plan, cost structure reduction        
Restructuring Cost and Reserve [Line Items]        
Percentage decrease in company workforce 60.00%      
Retention bonus costs       51,000
Severance costs       889,000
Corporate restructuring plan, retention and severance increases        
Restructuring Cost and Reserve [Line Items]        
Retention bonus costs       214,000
Severance costs       185,000
Annual bonus cost       410,000
Cash retention bonuses payable   603,000 603,000 603,000
Severance benefits payable upon change in control and termination without cause   $ 928,000 $ 928,000 $ 928,000